1. Yartemlea (narsoplimab-wuug) is the first on‑label complement inhibitor for hematopoietic stem cell transplant (HSCT) associated thrombotic microangiopathy, associated with improvements...

1. New FDA communication introduces a more flexible, risk‑based chemistry, manufacturing, and controls (CMC) framework for cell and gene therapies,...

1. Nuzolvence (zoliflodacin) is the first single‑dose oral agent for uncomplicated urogenital gonorrhea, showing non‑inferior cure rates to ceftriaxone‑based therapy...

Oral gonorrhea antibiotic Nuzolvence approved just weeks ago The Food and Drug Administration recently approved Nuzolvence (zoliflodacin) as a first‑in‑class...

1. Adnan and colleagues evaluated machine learning models’ ability to screen for Parkinson’s disease using self-recorded smile videos. 2. The...

Amryta’s Sodesta gene therapy gains accelerated approval for ALS The Food and Drug Administration has granted accelerated approval to Sodesta,...

1. The CDC has laid off roughly 1,300 employees as part of a sweeping restructuring, later reinstating about half amid...

1. New York has confirmed the first locally transmitted chikungunya infection in the United States since 2019. 2. Climate shifts...

1. A new WHO analysis finds one in six bacterial infections worldwide is now resistant to standard antibiotics. 2. Resistance...

1. Day and colleagues randomized sonographers to scan pregnant participants with AI assistance or the standard method for congenital heart...